Leaflet PIRAZINAMIDA ATB 500mg tablets

Product code:
W60213002
Quantity:
1500
Indicated for:
tuberculosis
Route of administration:
oral
Substance:
pyrazinamide (anti-tuberculosis agent)
ATC
J04AK01 — Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Other drugs for treatment of tuberculosis

Precautions:

Hepatotoxicity

Hepatotoxicity

This medicine may affect the liver.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Pyrazinamide is an antitubercular medication used in the treatment of tuberculosis, particularly in the initial phase of combination therapy. It works by inhibiting the synthesis of fatty acids essential for Mycobacterium tuberculosis, contributing to bacterial destruction.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor liver function.

Patients should be aware of potential side effects, such as nausea, joint pain, or symptoms of liver damage. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, joint pain, and elevated liver enzymes. In rare cases, severe reactions such as hepatitis or allergic reactions may occur. Patients should be informed of these risks before use.

General data about PIRAZINAMIDA ATB 500mg

Substance:
pyrazinamide
Date of latest medicines list:
01-06-2026
Product code:
W60213002
Concentration:
500mg
Pharmaceutical form:
tablets
Quantity:
1500
Product type:
Generic medicine
Price:
1037.05 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ANTIBIOTICE S.A. - ROMANIA
Holder:
ANTIBIOTICE S.A. - ROMANIA
Number:
5749/2013/02
Shelf life:
3 years

Compensation lists for PIRAZINAMIDA ATB 500mg Antibiotice

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price
1037.05 RON
Copayment
1037.05 RON
Patient
0.00 RON

NHP 1.B (C2) - Tuberculosis

Price
1037.05 RON
Copayment
1037.05 RON
Patient
0.00 RON